For instance, these compounds disrupt the YAP1–GLUT1 feedback loop, suppressing glycolysis in tumor cells while enhancing glucose uptake in CD8+ T cells to bolster antitumor immunity [75]. The gene discussed is SLC2A1; the disease is neoplasm.